Ezetimibe/simvastatin - Merck & Co
At a glance
- Drug Originator Merck/Schering-Plough Pharmaceuticals
- Drug Licenced by Daewoong Pharmaceutical; Rovi
- Drug Class Antihyperlipidaemics; Azetidines; Fluorobenzenes; Naphthalenes; Propanols; Small molecules
- Mechanism of Action Cholesterol absorption inhibitors; HMG-CoA reductase inhibitors; NPC1L1 protein inhibitors
- USA Patent Applicants ORGANON
- USA Patents 5
- NDAs 1
- Patent Applications 544
Table of Contents
Disclaimer